logo

For the Inventor, By the Inventor

Stow, MA, United States of America

Thomas D Chittenden

LinkedIn

This inventor holds 20 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignees: Immunogen, Inc., Apoptosis Technology, Inc.. Active years: 1997-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas D Chittenden. Retrieved from https://idiyas.com/inventor/thomas-d-chittenden

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 70.0

 

Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 125(Granted Patents)


Location History:

  • Brookline, MA (US) (1997 - 1999)
  • Stow, MA (US) (2001 - 2008)
  • Sudbury, MA (US) (2007 - 2024)

Company Filing History:

goldMedal17 out of 256 
 
Immunogen, Inc.
 patents
silverMedal3 out of 9 
 
Apoptosis Technology, Inc.
 patents

Years Active: 1997-2024

Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents
1. 11897961 - Anti-CD123 antibodies and conjugates and derivatives thereof (2024-02-13),
2. 11834498 - Biparatopic FR-alpha antibodies and immunoconjugates (2023-12-05),
3. 11396543 - Biparatopic FR-α antibodies and immunoconjugates (2022-07-26),
4. 11332535 - Anti-CD123 antibodies and conjugates and derivatives thereof (2022-05-17),
5. 10919969 - Anti-CD123 antibodies and conjugates and derivatives thereof (2021-02-16),
6. 10875925 - Anti-CD123 antibodies and conjugates and derivatives thereof (2020-12-29),
7. 10442865 - Methods of use of anti-CD123 antibodies and antigen-binding fragments thereof (2019-10-15),
8. 10077313 - Anti-CD123 antibodies and conjugates and derivatives thereof (2018-09-18),
9. 9238690 - Non-antagonistic EGFR-binding molecules and immunoconjugates thereof (2016-01-19),
10. 9233171 - Method of treatment of tumors that are resistant to EGFR antibody therapies by EGFR antibody cytotoxic agent conjugate (2016-01-12),
11. 9125896 - EGFR-binding molecules and immunoconjugates thereof (2015-09-08),
12. 8790649 - EGFR-binding molecules and immunoconjugates thereof (2014-07-29),
13. 7358088 - Peptides and compositions which modulate apoptosis (2008-04-15),
14. 7202346 - Antibodies to non-shed Muc1 and Muc16, and uses thereof (2007-04-10),
15. 7202024 - bbc3 Gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter (2007-04-10),

Title: Inventor Thomas D Chittenden - Pioneering Innovations in Stow, MA

Introduction: Thomas D Chittenden is a distinguished inventor based in Stow, MA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Thomas D Chittenden holds several patents in various technological domains, showcasing his versatility and ingenuity in creating novel solutions to complex problems.

Career Highlights: Throughout his illustrious career, Thomas D Chittenden has consistently pushed the boundaries of innovation, with a keen focus on developing cutting-edge technologies that have the potential to revolutionize industries.

Collaborations: Thomas D Chittenden has collaborated with leading research institutions, universities, and companies to further his research and bring his inventions to life. His collaborative spirit and dedication to excellence have earned him recognition in the innovation community.

Conclusion: In conclusion, Thomas D Chittenden stands as a visionary inventor whose passion for innovation and commitment to excellence continue to inspire the next generation of inventors and technologists.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…